The retail market for veterinary drugs in Russia increased by 17.7% in value terms in 2025, reaching 49.2 billion rubles, according to a report by аналитической компании RNC Pharma. In volume terms, growth was more modest: the market reached 276.8 million packages, up 13.2%. For comparison, in 2024 the growth rates were 16.8% in rubles and 9.4% in packages.
Analysts noted a decline in the average number of units per package, although for some products consumers still open packages in 70–90% of cases.
Online sales remain the key driver of the market. The share of the e-commerce channel reached 27.9% in value terms (compared to 21.6% a year earlier) and 24.1% in volume terms (up from 17.6%). Analysts emphasized that online platforms tend to focus on higher-priced products.
By the end of 2025, the share of Russian veterinary drugs in the retail market reached 56% in value terms, increasing by 8 percentage points compared to 48% the previous year. Analysts highlighted that Belarusian manufacturers showed the highest sales growth, increasing volumes by 54% compared to 2024. Russian companies ranked second with a 37% increase, followed by Slovenia, whose veterinary products grew by 30%.
At the same time, there has been a sharp decline in supplies from several European countries. The largest drops were recorded for Spain (-65%), the Czech Republic (-59%), and Latvia (-48%). France (-38%) and the Netherlands (-29%) also significantly reduced their market presence.
Inflation in the veterinary drug segment reached 13% by the end of the year. The structure of demand is shifting toward higher-priced products: the share of drugs costing more than 1,000 rubles per minimum unit approached 25%. Products priced between 500 and 1,000 rubles accounted for 21.8%, while the cheapest segment (under 100 rubles) made up 15.8%.
Earlier, RNC Pharma reported that spending by Russians on veterinary drugs in specialized pharmacies and pet stores exceeded 49.1 billion rubles in 2025, up 18% year-on-year. In volume terms, retail sales increased by 14%.
Source: GxP News, March 5, 2026.
